| 1991 |
β-COP (COPB2 paralog note: this paper describes β-COP/COPB1, but the 1993 paper PMID:8334999 identifies β'-COP/COPB2 as a distinct novel subunit) is a peripheral 110 kDa Golgi membrane protein present in a cytosolic ~550 kDa complex (~13-14S) and localizes to non-clathrin-coated vesicles and cisternae of the Golgi complex; GTPγS treatment causes accumulation of β-COP-positive coated vesicles in Golgi fractions. |
Protein cloning/sequencing, immunofluorescence, immunoelectron microscopy, subcellular fractionation |
Cell |
High |
1840503
|
| 1993 |
β'-COP (COPB2) is a novel stoichiometric subunit of the coatomer complex, present in both cytosolic coatomer and non-clathrin-coated vesicles, and shows homology to β-subunits of trimeric G proteins (WD40 repeats). |
Biochemical purification of coatomer, SDS-PAGE on urea-containing gels, cross-reactivity with anti-peptide antibody, N-terminal sequence analysis |
The EMBO journal |
High |
8334999
|
| 1993 |
β-COP is essential for ER-to-Golgi biosynthetic membrane transport in vivo; microinjection of anti-β-COP antibodies blocks transport of VSV-G glycoprotein from the ER and intermediate compartment (but not from the TGN), arresting cargo in tubular structures at the ER-Golgi interface and inhibiting endoglycosidase H resistance acquisition. |
Microinjection of antibodies, temperature-block transport assay, VSV-G trafficking, endoglycosidase H resistance assay, immunofluorescence |
Cell |
High |
8334707
|
| 1993 |
β-COP is required for ER-to-cis-Golgi vesicle budding in vitro; anti-β-COP antibodies/Fab fragments prevent VSV-G exit from the ER. A high-molecular-weight β-COP-containing complex (>1,000 kDa, distinct from coatomer) promotes ER vesicle budding, and Rab1B co-precipitates with this complex and is also essential for its function. |
In vitro ER-to-Golgi transport assay, antibody inhibition, cytosol fractionation, co-immunoprecipitation with Rab1B |
The Journal of cell biology |
High |
8376457
|
| 1993 |
β-COP localizes predominantly to the cis-Golgi side in exocrine pancreas (68% of Golgi-associated label on cis-side); energy depletion redistributes β-COP to spherical aggregates at the cis-Golgi; BFA treatment causes >90% of β-COP to become cytoplasmic; AlF treatment causes fragmentation of Golgi into β-COP-positive vesicle clusters. |
Immunogold electron microscopy, energy depletion, BFA and AlF treatment, quantitative immunocytochemistry |
The Journal of cell biology |
High |
8458872
|
| 1991 |
ARF (ADP-ribosylation factor) is required for binding of β-COP (coatomer) to Golgi membranes; coatomer resolved from ARF does not bind Golgi membranes, but binding is reconstituted by addition of recombinant ARF. Brefeldin A blocks β-COP membrane association by interfering with the initial ARF-membrane interaction step. |
Reconstitution binding assay with resolved fractions, ARF N-terminal peptide inhibition, BFA treatment |
Proceedings of the National Academy of Sciences of the United States of America |
High |
1631136
|
| 1991 |
βγ subunits of heterotrimeric G proteins inhibit the GTPγS-stimulated association of both ARF and β-COP with Golgi membranes, suggesting that trimeric G proteins regulate coat protein assembly onto Golgi membranes. |
Membrane binding assay with purified βγ subunits added to semi-intact cells |
Science |
Medium |
1957170
|
| 1997 |
β'-COP (COPB2) is a selective RACK (receptor for activated C-kinase) for PKCε; it was isolated by screening with the PKCε V1 region, contains seven WD40 repeats, and activated PKCε colocalizes with β'-COP in cardiac myocytes and binds Golgi membranes in a β'-COP-dependent manner. |
cDNA library screening with PKCε V1 bait, co-localization by immunofluorescence, binding assay on Golgi membranes |
The Journal of biological chemistry |
Medium |
9360998
|
| 1994 |
HIV-1 Nef physically interacts with β-COP (COPB2); identified by yeast two-hybrid screening and confirmed by in vitro binding and co-immunoprecipitation from HIV-1-infected cells. |
Yeast two-hybrid, in vitro binding assay, co-immunoprecipitation |
The Journal of biological chemistry |
Medium |
7982906
|
| 1999 |
HIV-1 Nef recruits β-COP (COPB2) in endosomes via a diacidic motif to target internalized CD4 for lysosomal degradation; a sequence encompassing a critical acidic dipeptide in Nef's C-terminal loop is responsible for β-COP recruitment and routing to lysosomes. |
Mutagenesis of Nef diacidic motif, co-immunoprecipitation, subcellular fractionation, CD4 degradation assay |
Cell |
Medium |
10199403
|
| 2001 |
Mutation of the diacidic (glutamate) residues in HIV-1 Nef does not significantly affect its ability to interact with β-COP, downregulate CD4 surface expression, or route cargo to the endocytic pathway — indicating these acidic residues are NOT the β-COP-binding determinant as previously proposed. |
Site-directed mutagenesis of Nef diacidic motif, co-immunoprecipitation, CD4 surface downregulation assay, endocytic routing assay |
Journal of virology |
Medium |
11264386
|
| 2008 |
HIV-1 Nef contains two separable β-COP-binding sites: an RXR motif in the N-terminal α-helical domain required for maximal MHC-I degradation, and a di-acidic motif in the C-terminal loop needed for efficient CD4 degradation. Both MHC-I and CD4 are ultimately targeted for degradation via β-COP activity in the same Rab7+ vesicles. |
Mutagenesis of Nef RXR and di-acidic motifs, co-immunoprecipitation, MHC-I and CD4 degradation assays, Rab7 co-localization |
PLoS pathogens |
Medium |
18725938
|
| 2003 |
The WD40 domain of β'-COP (COPB2/Sec27 in yeast) mediates cargo-selective interaction with KTKLL-type di-lysine motifs and is required for recycling of Emp47p back to the ER; the two WD40 domains of α-COP and β'-COP bind distinct but overlapping sets of di-lysine signals, and loss of both WD40 domains is lethal in yeast. |
Yeast genetics (point mutations and domain deletions in sec27), two-hybrid, turnover assay for Emp47p, invertase maturation assay |
Molecular biology of the cell |
High |
14699056
|
| 2000 |
Rab2 requires PKC ι/λ to recruit β-COP to pre-Golgi intermediate (VTC) membranes; PKC ι/λ translocates to membranes in a Rab2-dependent manner, and depletion of PKC ι/λ prevents β-COP recruitment. PKC ι/λ kinase activity (but not its structural presence) is required for Rab2-mediated vesicle budding. |
Quantitative membrane binding assay, antibody depletion of PKC isoforms, kinase-deficient PKC mutant, pseudosubstrate peptide inhibition |
Traffic |
Medium |
11208158
|
| 2006 |
Stomach-specific calpain nCL-2 (calpain-8a) co-localizes with β-COP at the Golgi in COS7 cells and proteolytically cleaves β-COP near its linker region in vitro and in cells upon Ca2+-ionophore stimulation, causing dissociation of β-COP from the Golgi. |
Yeast two-hybrid, co-localization by immunofluorescence, in vitro proteolysis assay, Ca2+-ionophore stimulation, Western blot |
The Journal of biological chemistry |
Medium |
16476741
|
| 2008 |
siRNA-mediated depletion of β-COP (COPB2) causes co-localization of ERGIC, Golgi, TGN, and recycling endosome markers in large globular compartments, arrests anterograde trafficking of VSV-G and caveolin-1 (Cav1), and perturbs transferrin recycling; Cav1 co-precipitates with γ-COP subunit, identifying it as a COP-I cargo. |
siRNA knockdown, immunofluorescence, VSV-G trafficking assay, co-immunoprecipitation of Cav1 with γ-COP |
American journal of physiology. Cell physiology |
Medium |
18385291
|
| 2010 |
β-COP interacts with the N-terminal region of TREK1 K+ channel (identified by yeast two-hybrid); co-expression of β-COP with TREK1 increases channel surface expression and activity, while β-COP shRNA reduces TREK1 surface expression. |
Yeast two-hybrid, co-immunoprecipitation, GST pulldown, surface biotinylation, patch-clamp electrophysiology, shRNA knockdown |
Biochemical and biophysical research communications |
Medium |
20362547
|
| 2010 |
β-COP interacts with the Na,K-ATPase α-subunit via a dibasic motif at Lys54; in the absence of the Na,K-ATPase β-subunit, the α-subunit interacts with β-COP and is retained in the ER for degradation. Mutation of Lys54 abolishes β-COP interaction and allows α-subunit trafficking to the plasma membrane without β-subunit assembly. |
Novel labeling technique, co-immunoprecipitation, pulse-chase, site-directed mutagenesis of Lys54, ER retention assay |
The Journal of biological chemistry |
High |
20801885
|
| 2004 |
β'-COP (COPB2) directly binds ADIP (afadin- and α-actinin-binding protein); ADIP co-localizes with β'-COP at the Golgi complex in MDCK and NRK cells, suggesting involvement of β'-COP in Golgi-ER vesicle trafficking through interaction with this adherens junction protein. |
Yeast two-hybrid, co-immunoprecipitation, co-localization by immunofluorescence |
Biochemical and biophysical research communications |
Low |
15358183
|
| 2016 |
β-COP (COPB2) directly interacts with ANO1 (Anoctamin-1 chloride channel); co-expression of β-COP with ANO1 decreases ANO1 surface expression and channel activity, and β-COP silencing in U251 glioblastoma cells enhances endogenous ANO1 surface expression and whole-cell currents. |
Yeast two-hybrid, co-immunoprecipitation, GST pulldown, surface biotinylation, patch-clamp electrophysiology, β-COP siRNA |
Biochemical and biophysical research communications |
Medium |
27207835
|
| 2017 |
The Orientia tsutsugamushi effector Ank9 binds host COPB2, which mediates Golgi-to-ER retrograde transport; COPB2 siRNA treatment destabilizes the Golgi similarly to Ank9 expression, and COPB2 reduction benefits Orientia intracellular replication. |
Co-immunoprecipitation, siRNA knockdown, Golgi morphology assay, intracellular replication assay |
Cellular microbiology |
Medium |
28103630
|
| 2017 |
Homozygous loss-of-function of Copb2 is lethal at early embryogenesis in mice; compound heterozygotes (Copb2R254C/Zfn, carrying the human microcephaly-associated R254C substitution in a WD40 domain) show perinatal lethality, increased apoptosis in the brain, reduced layer V (CTIP2+) neurons, and neurosphere growth defects. |
CRISPR-Cas9 allelic series generation, mouse genetics, immunostaining (CTIP2), TUNEL apoptosis assay, neurosphere growth assay |
Human molecular genetics |
High |
29036432
|
| 2019 |
β-COP (COPB2) is involved in apolipoprotein-mediated cholesterol exocytosis; β-COP knockdown reduces apoA-1-mediated cholesterol efflux in THP-1 macrophages, β-COP co-localizes with apoA-1/apoE on membrane protrusion complexes during cholesterol efflux, and apoA-1 promotes β-COP translocation to the cell membrane. |
lentiviral shRNA knockdown, confocal microscopy, immunogold electron microscopy, cholesterol efflux assay, Western blot, proteomics |
PloS one |
Medium |
26986486
|
| 2021 |
COPB2 knockdown in mutant EGFR NSCLC cells alters post-translational processing of receptor tyrosine kinases (RTKs) and activates the ER stress response pathway; the small molecule EMI66 alters electrophoretic mobility and subcellular localization of COPB2 within the early secretory pathway and recapitulates RTK expression changes. |
siRNA knockdown, Western blot, immunofluorescence for subcellular localization, small molecule treatment (EMI66), organoid growth assay |
Journal of molecular biology |
Medium |
34662547
|
| 2022 |
β-COP directly binds TREK1 (but not TWIK1) in the TWIK1/TREK1 heterodimeric channel complex in astrocytes; β-COP enhances surface expression of the TWIK1/TREK1 heterodimer in a TREK1-dependent manner and thereby regulates passive conductance (background K+ current) in mouse brain astrocytes. |
Co-immunoprecipitation, surface biotinylation, patch-clamp electrophysiology in astrocytes, heterologous expression system |
Cells |
Medium |
36291187
|
| 2023 |
β-COP binds the C-terminus of TREK2 (but not TRAAK) and reduces TREK2 surface expression; C-terminal deletion or point mutations in TREK2 abolish β-COP binding and prevent β-COP-mediated reduction of surface expression. |
Co-immunoprecipitation, surface biotinylation, mutagenesis of TREK2 C-terminus |
Cells |
Medium |
37296621
|
| 2019 |
β-COP (COPB2) directly interacts with TTYH2 anion channel (identified by yeast two-hybrid); co-expression of β-COP reduces surface expression and activity of TTYH2, and overexpression of β-COP in LoVo colon cancer cells decreases endogenous TTYH2 surface expression and activity. |
Yeast two-hybrid, co-immunoprecipitation, GST pulldown, surface biotinylation, whole-cell current recording, β-COP overexpression |
BMB reports |
Medium |
30670146
|
| 2024 |
β'-COP (COPB2) directly interacts with PPARγ in trophoblasts (validated by co-immunoprecipitation and molecular dynamics simulation identifying critical binding sites); β'-COP mediates sorting of PPARγ into early endosomes and multivesicular bodies for incorporation into extracellular vesicles, and knockout of β'-COP impairs PPARγ loading into EVs. |
Co-immunoprecipitation, molecular dynamics simulation, lentiviral knockout and overexpression, proteomic analysis of EVs |
Cellular and molecular life sciences |
Medium |
39601826
|
| 2025 |
β'-COP (COPB2) interacts with EDEM3 (an ERAD enzyme) in ovarian cancer cells, enhancing EDEM3 ER localization and its mannose-trimming function; COPB2 depletion impairs EDEM3 activity, causes glycan processing defects and ER stress accumulation. |
Co-immunoprecipitation, glycoproteomic analysis, COPB2 knockdown/overexpression, ER stress assays, xenograft in vivo model |
Cellular oncology |
Medium |
40736660
|
| 2025 |
Inhibitory peptides derived from PKCε (KxKxx motif pentapeptides with C-terminal carboxylate, especially KIKIC) potently inhibit the PKCε–RACK2/COPB2 interaction in a proximity-based assay; alanine scanning confirmed the two Lys residues and C-terminal carboxylate as critical. KIKIC modifies PKCε translocation in cells, and RACK2 pulldown identified several proteins in a PKCε-RACK2 complex in a KIKIC-sensitive manner. |
Proximity-based chemiluminescent binding assay, alanine scan mutagenesis, PKCε translocation assay, RACK2 pulldown with mass spectrometry |
Biochimica et biophysica acta. Molecular cell research |
Medium |
41115472
|
| 2025 |
Knockdown of COPB2 (along with other COPI subunits COPA, COPB1, COPG1, ARCN1, COPZ1) in Huh-7 hepatocarcinoma cells decreases uptake of HDL holoparticles and selective HDL lipid uptake by reducing cell surface SR-BI abundance and its glycosylation; COPB2 knockdown also decreases APOA1 expression and apoA-I secretion but increases cell-surface ABCA1 abundance and ABCA1-mediated cholesterol efflux. |
Genome-wide RNAi screen, targeted siRNA knockdown validation, flow cytometry for surface receptor abundance, cholesterol efflux assay, apoA-I secretion assay |
bioRxivpreprint |
Medium |
|